Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 18Glioma 14Brain Neoplasms 13Neoplasms 3Astrocytoma 3Meningioma 2Gliosarcoma 2Diffuse Intrinsic Pontine Glioma 2Venous Thromboembolism 1Surgical Wound Infection 1Stroke 1Spinal Diseases 1Spinal Cord Neoplasms 1Seizures 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroma 1Neurofibromatosis 1 1Neurofibromatoses 1Neuroblastoma 1Neurilemmoma 1Motor Activity 1Melanoma 1Liver Neoplasms 1Intracranial Hypertension 1Hydrocephalus 1Hemangioma, Capillary 1

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neuroma × CNS × Clear all
NCT01083966 2026-06-01

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Northwell Health

Phase 1 Suspended
30 enrolled
CNS

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡